From the Editor-in-Chief
Can cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
Your Tax Dollars at Work | Treatment Before Surgery | Opportunities for Prevention | Tinkering With T Cells | Palliative Care Can Help a Wide Range of Patients | Improving Patient Care Worldwide
Learn what questions to ask before participating in a study.
by Hester Hill Schnipper
Caregiving With Confidence
Shifting some responsibilities may empower your loved one and strengthen your relationship.
by Aimee Swartz
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
Advocacy In Action
Lori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
Vitamin D Doubts | A Virtuous Cycle
During her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
Learn how to help a depressed parent with cancer.
Cancer survivor creates scholarship fund for young adult cancer survivors.
by Lindsey Konkel
Wanda Huskins, Renee Soriano, Holly Hamer.
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
A new vaccine is safe for cancer patients but hard to find.
by Nancy Averett
In the past few decades, most of the progress that has been made against cervical cancer has been in the areas of prevention and early detection.
The U.S. Food and Drug Administration rounded out 2018 with three oncology approvals.
What are the side effects of immune checkpoint inhibitors and how do they arise?
Bob Riter: The Bridge Builder
donate to the AACR